Abstract:Enterovirus A71 (EV-A71) is one of the major causative agents of hand-foot-and-mouth disease (HFMD) that majorly affects children. Most of the time, HFMD is a mild disease but can progress to severe complications such as meningitis, brain stem encephalitis, acute flaccid paralysis (AFP) and even death. HFMD caused by EV-A71 has emerged as an acutely infectious disease of highly pathogenic potential in the Asia-Pacific region. In this review, we introduced the properties and life cycle of EV-A71, the pathogenesis and the pathophysiology of EV-A71 infection, including: tissue tropism and host range of virus infection, the diseases caused by the virus, as well as the genes and host cell immune mechanisms of major diseases caused by EV71 infection, such as encephalitis and neurological pulmonary edema. At the same time, clinicopathological characteristics of EV71 infection were introduced. There is currently no specific medication for EV-A71 infection, highlighting the urgency and significance of developing suitable anti-EV-A71 agents. This overview also summarizes the targets of existing anti-EV-A71 agents, including virus entry, translation, polyprotein processing, replication, assembly and release; interferons (IFNs); interleukin (IL); the mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K), and protein kinase B (Akt) signaling pathways; the oxidative stress pathway; and the ubiquitin-proteasome system, et al. Furthermore, it overviews the effects of natural products, monoclonal antibodies, and RNA interference against EV-A71. It also discusses issues limiting the research of antiviral drugs. This review is a systematic and comprehensive summary of the mechanism and pathological characteristics of EV71 infection, the latest progress of existing anti-EV-A71 agents. It would provide better understanding and guidance for the research and application of EV71 infection and antiviral inhibitors.

Structure and function of enterovirus 71 3D protein

Structure and function of enterovirus 713D protein

Analysis of the Complete Genomes of Enterovirus 71 Subtypes in China.

PATHOGEN SPECTRUM ANALYSIS OF HAND, FOOT AND MOUTH DISEASE AND GENETIC ANALYSIS OF THE VP1 REGION OF HUMAN ENTEROVIRUS 71 ISOLATED STRAINS IN HANGZHOU

Progress in Research on Structure, Function and Antiviral of Enterovirus A71 3C Protein

The Golgi Protein ACBD3 Facilitates Enterovirus 71 Replication by Interacting with 3A

Structure of the Enterovirus 71 3C Protease in Complex with NK-1.8k and Indications for the Development of Antienterovirus Protease Inhibitor

Recent advances in enterovirus A71 infection and antiviral agents

Crystal Structure of Human Enterovirus 71 3C Protease

Progress in the functional genomics researches on human enterovirus 71

Research Progress of the Structure and Function of Untranslated Regions of Enterovirus 71 Genome

Determination of the Cleavage Site of Enterovirus 71 VP0 and the Effect of This Cleavage on Viral Infectivity and Assembly.

Review of hand, foot and mouth disease

Activation of Host Cellular Signaling and Mechanism of Enterovirus 71 Viral Proteins Associated with Hand, Foot and Mouth Disease

Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China

Progress of severe hand-foot-mouth disease infected by EV71 virus

The pathogenesis during enterovirus 71-induced HFMD

Epidemiological Characteristics of Severe Hand Foot and Mouth Disease and Research Progress of Enterovirus 71 Vaccine

Advances in the Study of Enterovirus 71 Infection

Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors As Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease.

The molecular mechanisms of enterovirus A71 evading host innate immunity